KALV
NASDAQ HealthcareKalVista Pharmaceuticals, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $17.38 |
|---|---|
| Volume | 1,282,683 |
| Market Cap | 878.49M |
| Beta | -0.290 |
| RSI (14-Day) | 63.2 |
| 200-Day MA | $13.95 |
| 50-Day MA | $15.78 |
| 52-Week High | $19.00 |
| 52-Week Low | $9.23 |
| Forward P/E | -11.74 |
| Price / Book | 51.73 |
🎯 Investment Strategy Scores
How KALV scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
47/100
High dividend yield + low volatility
🚀 Moon Shot
1/100
High growth potential (high beta + oversold)
🔪 Falling Knife
9/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
90/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
23/100
Large-cap, institutional-quality stocks
Find KALV in your text
Paste any text on the homepage — the tool will extract KALV and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.